Mendelian randomization: genetic anchors for causal inference in epidemiological studies
- PMID: 25064373
- PMCID: PMC4170722
- DOI: 10.1093/hmg/ddu328
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Abstract
Observational epidemiological studies are prone to confounding, reverse causation and various biases and have generated findings that have proved to be unreliable indicators of the causal effects of modifiable exposures on disease outcomes. Mendelian randomization (MR) is a method that utilizes genetic variants that are robustly associated with such modifiable exposures to generate more reliable evidence regarding which interventions should produce health benefits. The approach is being widely applied, and various ways to strengthen inference given the known potential limitations of MR are now available. Developments of MR, including two-sample MR, bidirectional MR, network MR, two-step MR, factorial MR and multiphenotype MR, are outlined in this review. The integration of genetic information into population-based epidemiological studies presents translational opportunities, which capitalize on the investment in genomic discovery research.
© The Author 2014. Published by Oxford University Press.
Figures


Similar articles
-
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):995-1010. doi: 10.1158/1055-9965.EPI-17-1177. Epub 2018 Jun 25. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29941659 Free PMC article. Review.
-
Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.Cancer Causes Control. 2022 May;33(5):631-652. doi: 10.1007/s10552-022-01562-1. Epub 2022 Mar 11. Cancer Causes Control. 2022. PMID: 35274198 Free PMC article.
-
'Mendelian randomization': an approach for exploring causal relations in epidemiology.Public Health. 2017 Apr;145:113-119. doi: 10.1016/j.puhe.2016.12.033. Epub 2017 Jan 21. Public Health. 2017. PMID: 28359378 Review.
-
Causal inference in health and disease: a review of the principles and applications of Mendelian randomization.J Bone Miner Res. 2024 Oct 29;39(11):1539-1552. doi: 10.1093/jbmr/zjae136. J Bone Miner Res. 2024. PMID: 39167758 Free PMC article. Review.
-
Mendelian randomization studies on atherosclerotic cardiovascular disease: evidence and limitations.Sci China Life Sci. 2019 Jun;62(6):758-770. doi: 10.1007/s11427-019-9537-4. Epub 2019 May 17. Sci China Life Sci. 2019. PMID: 31104264 Review.
Cited by
-
Association between fruit intake and non-small cell lung cancer: a Mendelian randomization study.Transl Lung Cancer Res. 2024 Sep 30;13(9):2388-2394. doi: 10.21037/tlcr-24-276. Epub 2024 Sep 27. Transl Lung Cancer Res. 2024. PMID: 39430331 Free PMC article.
-
Causal effects of obstructive sleep apnea on chronic kidney disease and renal function: a bidirectional Mendelian randomization study.Front Neurol. 2024 Sep 4;15:1323928. doi: 10.3389/fneur.2024.1323928. eCollection 2024. Front Neurol. 2024. PMID: 39296957 Free PMC article.
-
Impact of thyroid function on coagulation and venous thromboembolism: a two-sample mendelian randomization study.J Thromb Thrombolysis. 2024 Oct;57(7):1145-1153. doi: 10.1007/s11239-024-03025-7. Epub 2024 Aug 7. J Thromb Thrombolysis. 2024. PMID: 39110374
-
Causal Relationship Between Sleep Traits and Hypothalamic-Pituitary-Target Gland Axis Function: A Mendelian Randomization Study.Nat Sci Sleep. 2024 Feb 16;16:155-175. doi: 10.2147/NSS.S442231. eCollection 2024. Nat Sci Sleep. 2024. PMID: 38379755 Free PMC article.
-
Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study.Front Genet. 2024 Jan 22;14:1260352. doi: 10.3389/fgene.2023.1260352. eCollection 2023. Front Genet. 2024. PMID: 38318289 Free PMC article.
References
-
- Davey Smith G., Ebrahim S. Epidemiology—is it time to call it a day? Int. J. Epidemiol. 2001;30:1–11. - PubMed
-
- Davey Smith G., Ebrahim G. Folate Supplementation and cardiovascular disease. Lancet. 2005;366:1679–1681. - PubMed
-
- Barter P.J., Caulfield M., Eriksson M., Grundy S.M., Kastelein J.J., Komajda M., Lopez-Sendon J., Mosca L., Tardif J.C., Waters D.D., et al. ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 2007;357:2109–2122. - PubMed
-
- Fewell Z., Davey Smith G., Sterne J.A.C. The impact of residual and unmeasured confounding in epidemiological studies; a simulation study. Am. J. Epidemiol. 2007;166:646–655. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources